Pacira BioSciences (PCRX) Profit After Tax (2010 - 2026)

Pacira BioSciences' Profit After Tax history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 39.4% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $5.1 million (up 104.95% YoY), while the FY2025 annual figure was $7.0 million, up 107.07% from the prior year.
• Profit After Tax was $2.9 million for Q1 2026 at Pacira BioSciences, up from $1.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $25.8 million in Q2 2023 to a low of -$143.5 million in Q3 2024.
• Historically, Profit After Tax has averaged -$1.9 million across 5 years, with a median of $5.4 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Profit After Tax soared 1666.81% in 2023, then slumped 1421.29% in 2024.
• A 5-year view of Profit After Tax shows it stood at -$10.1 million in 2022, then soared by 346.19% to $24.9 million in 2023, then plunged by 35.5% to $16.0 million in 2024, then slumped by 89.79% to $1.6 million in 2025, then soared by 78.13% to $2.9 million in 2026.
• The last three Profit After Tax figures came in at $2.9 million (Q1 2026), $1.6 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.